Skip to content

    Dhanuka Agritech

    DHANUKA
    Chemicals·1 Aug 2025
    Management Summary

    Dhanuka Agritech reported a 7% YoY revenue growth to ₹528.29 crores and a 13.5% increase in PAT to ₹55.5 crores for Q1 FY26, despite a challenging monsoon season impacting herbicide demand. The company launched a new paddy herbicide, Dinkar, and remains committed to double-digit revenue growth for FY26, though anticipating a 100 bps decline in EBITDA margin. Capital allocation included a final dividend and a ₹100 crore share buyback.

    Highlights

    5
    • Revenue from operations grew 7% YoY to ₹528.29 crores, indicating resilience despite challenging market conditions.

    • EBITDA increased by 15.9% YoY to ₹83.19 crores, demonstrating operational efficiency.

    • Profit after tax grew 13.5% YoY to ₹55.5 crores.

    • Successfully launched a new 9(3) product, Dinkar (paddy herbicide), which received an encouraging response.

    • Committed to achieving double-digit revenue growth for the full financial year.

    Concerns

    4
    • Q1 FY26 revenue growth was single-digit (7%) due to delayed and uneven Southwest monsoon, leading to subdued demand for agri imports, particularly herbicides.

    • Channel inventories remained elevated in certain regions, especially for herbicides in soybean and cotton growing areas.

    • Management expects a 100 basis point decline in EBITDA margin for FY26 due to the ban on a highly profitable biofertilizer molecule and stabilization of technical prices.

    • An investment in IoTechWorld Avigation was marked down from ₹31 crores to ₹22.5 crores based on a valuation report.

    Key financials

    Metrics

    5

    Periods

    2

    Headline

    3
    • Revenue from Operations
      ₹528.29 Cr
      YoY+7.0%
    • EBITDA
      ₹83.19 Cr
    • Profit After Tax
      ₹55.5 Cr

    Q1

    2
    • Dahej Plant Revenue
      ₹16.5 Cr
    • Royalty Income
      ₹9 Cr

    Segment breakdown

    Zone-wise Turnover Q1 FY26
    31% North India9% East India41% West India19% South India
    Product Category-wise Turnover Q1 FY26
    23% Insecticides11% Fungicides50% Herbicides16% Others
    List

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Dividend

    ₹2/share (final)

    Buyback

    ₹100 crores

    Max ₹2,000/sh

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    Revenue Growth
    double-digit growth
    High
    Revenue
    Dahej Plant Revenue
    INR65 crores
    High
    Margin
    EBITDA Margin
    100 basis point decline
    High
    Capacity
    Dahej Plant Capacity Utilization
    close to 60%
    High
    Realization
    Technical Prices
    2% increase
    Medium
    New Products
    Second product from Dahej plant
    introduced
    High
    New Products
    Additional new products
    at least 2 more me-too products
    High

    Double-digit revenue growth

    FY26
    Current7% YoY in Q1 FY26
    TargetDouble-digit growth for FY26

    Why it matters

    To confirm the company's ability to recover from a soft Q1 and achieve its full-year growth target.

    Yes. So in terms of revenue, we are committed to a double-digit growth, maybe smaller, but we are sticking to our double-digit growth objective.

    How to verify

    key_financials.metrics[label='Revenue from Operations']

    Risks & concerns

    4
    RiskSeverity

    Delayed and uneven Southwest monsoon

    Impacted timely sowing of Kharif crops, leading to subdued demand for agri imports, particularly herbicides, and caused resowing in many places.Management acknowledged

    high

    Elevated channel inventories

    Remained elevated in certain regions, especially for herbicides in soybean and cotton growing areas, affecting primary sales.Management acknowledged

    medium

    EBITDA margin compression

    Expected 100 bps decline for FY26 due to the ban on a highly profitable biofertilizer molecule and stabilization of technical prices.Management acknowledged

    high

    Investment markdown

    Investment in IoTechWorld Avigation marked down from ₹31 crores to ₹22.5 crores based on valuation.Management acknowledged

    low

    Q&A highlights

    8

    “Right. So monsoon did happen the way it happened. And when it was raining in May, that rain was actually out of place and not the monsoon rains, so to say. And that rain did not do much to help some critical crops like soybean and cotton. In fact, it led to resowing in many places, which means that whatever farmer had sown got wasted and farmer had to go again for sowing the seeds. So that was a resowing that happened. And there was a mismatch in the crop cycle and the consumption opportunity because of which this quarter has shown single-digit growth.”

    Explains the reasons behind the subdued 7% revenue growth despite an early monsoon, highlighting operational challenges for farmers and the company.

    asked by Bhavya Gandhi

    2 min read7 chapters

    Detailed Narrative

    01

    Q1 FY26 Financial Performance Overview

    Dhanuka Agritech reported a 7% year-on-year growth in revenue from operations, reaching ₹528.29 crores for Q1 FY26, compared to ₹493.58 crores in Q1 FY25. EBITDA for the quarter stood at ₹83.19 crores, up from ₹71.72 crores in the prior year, while Profit After Tax increased to ₹55.5 crores from ₹48.89 crores. The company's shareholders declared a final dividend of ₹2 per equity share at the 40th Annual General Meeting.

    02

    Monsoon Impact and Market Challenges

    The April to June 2025 quarter was challenging for the Indian agrochemical industry due to a delayed and uneven Southwest monsoon. This impacted timely sowing of Kharif crops and led to subdued demand for agri imports, particularly herbicides. Farmers exercised caution in purchases, and early, out-of-place rains caused resowing in many areas, creating a mismatch in crop cycles and consumption opportunities. Channel inventories remained elevated, especially in herbicide-heavy regions like Madhya Pradesh, Maharashtra, Karnataka, and Telangana.

    03

    Product Portfolio and New Launches

    Herbicides constituted 50% of the product category-wise turnover in Q1 FY26, followed by insecticides at 23% and fungicides at 11%. The company introduced a new 9(3) product, Dinkar, a paddy herbicide from Hokko Chemical Japan, which received an encouraging response, particularly in the South region. Upcoming launches include Kinzan (a fungicide from Nissan, Japan) for grapes and potato, and Melody Duo (acquired from Bayer Crop Science). At least two more me-too products are planned for launch this year.

    04

    Dahej Plant Operations and Outlook

    The Dahej plant is currently manufacturing one product, with a second product slated for introduction in H2 FY26. For the full financial year, the company expects the Dahej plant to generate ₹65 crores in revenue and achieve approximately 60% capacity utilization. In Q1 FY26, the Dahej plant contributed ₹16.5 crores in revenue but incurred EBITDA losses of ₹3 crores.

    05

    Margin Outlook and Contributing Factors

    Management anticipates a 100 basis point decline in the EBITDA margin for FY26. This is primarily attributed to the ban on a highly profitable biofertilizer molecule, which negatively impacted the product mix. Additionally, the advantage from declining technical prices, seen in the previous year, has now ceased as prices have stabilized, contributing to the expected margin compression.

    06

    Capital Allocation and Strategic Investments

    Beyond the final dividend, Dhanuka Agritech completed a buyback of 5 lakh equity shares at ₹2,000 per share, absorbing ₹100 crores. The company also disclosed a markdown of its investment in IoTechWorld Avigation, a liquid drone manufacturing company, from ₹31 crores to ₹22.5 crores, based on a valuation report. Discussions for CDMO contracts are ongoing, but no deals have been signed yet.

    07

    Export Strategy and Market Diversification

    The export registration portfolio focuses on products manufactured at the Dahej plant (currently bifenthrin) and the Melody range. The company is in the process of applying for registrations in 6-7 additional countries this year. The Melody range and triadimenol products are already registered in over 25 countries globally, indicating a push towards international market expansion.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.